Schonfeld Strategic Advisors LLC Molecular Templates, Inc. Transaction History

Schonfeld Strategic Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.82 - $12.44 $116,518 - $185,356	-14,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.33 - $14.05 $25,191 - $37,935	2,700 Added 22.13%	14,900 $188,000
Q4 2020 Feb 16, 2021	SELL	$8.48 - $12.23 $128,896 - $185,896	-15,200 Reduced 55.47%	12,200 $114,000
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $74,925 - $108,075	7,500 Added 37.69%	27,400 $0
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $244,372 - $350,837	19,900 New	19,900 $274,000
Q1 2020 May 15, 2020	SELL	$11.31 - $18.26 $453,531 - $732,226	-40,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.44 - $14.21 $258,244 - $569,821	40,100 New	40,100 $561,000
Q2 2019 Aug 14, 2019	SELL	$5.83 - $8.42 $583,000 - $842,000	-100,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$4.02 - $5.81 $200,999 - $290,500	-50,000 Reduced 33.33%	100,000 $581,000
Q4 2018 Feb 14, 2019	SELL	$3.35 - $5.68 $17,755 - $30,104	-5,300 Reduced 3.41%	150,000 $606,000
Q3 2018 Nov 14, 2018	BUY	$4.07 - $6.25 $632,071 - $970,625	155,300 New	155,300 $838,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.